I totally agree. The greed of the pharmaceutical with their lobbyist to stop the government from making it a schedule III drug so much more research can be done. They do not care about the people, just money. We the people must rise up and let our government know, we care more about our friends and family than the money they give, to you congress men/women and senators get, and we VOTE. The only power we have is writing or calling congress men/women and senators, huge rallies and each and every ones VOTE. They would rather stay in office, than even receive big monies from big pharm for their campaigns. VOTES will win over.
But before you do that, know that all hemp CBD oils are not created equal! A recent study published in the Journal of the American Medical Association found nearly 70 percent of hemp CBD oil sold online was mislabeled. During the Penn Medicine study, researchers analyzed 84 products purchased from 31 companies. Around 42 percent of products were under-labeled, meaning the product contained more CBD than labeled. Twenty-six percent of products contained less CBD than indicated on packaging.
Despite advanced analytical techniques, much of the cannabis used recreationally is inaccurately classified. One laboratory at the University of British Columbia found that Jamaican Lamb's Bread, claimed to be 100% sativa, was in fact almost 100% indica (the opposite strain). Legalization of cannabis in Canada (as of October 17, 2018) may help spur private-sector research, especially in terms of diversification of strains. It should also improve classification accuracy for cannabis used recreationally. Legalization coupled with Canadian government (Health Canada) oversight of production and labelling will likely result in more—and more accurate—testing to determine exact strains and content. Furthermore, the rise of craft cannabis growers in Canada should ensure quality, experimentation/research, and diversification of strains among private-sector producers.
Because C. sativa has been a neglected crop for so long in North America, there are only negligible genetic resources available on this continent. Most germplasm stocks of hemp are in Europe, and the largest and most important collection is the Vavilov Institute gene bank in Leningrad. Figure 11 shows THC concentrations in the Vavilov collection, as well as in our own collection, largely of European germplasm. A disturbingly high percentage of the collections have THC levels higher than 0.3%, making it difficult to incorporate these into breeding programs.
A 2014 study stated that, “The endocannabinoid system has been elucidated over the last several years, demonstrating a significant interface with pain homeostasis. Exogenous (plant-based) cannabinoids have been demonstrated to be effective in a range of experimental neuropathic pain models, and there is mounting evidence for therapeutic use in human neuropathic pain conditions.”
If you live in a state where CBD is legal for your condition, it’s best to buy it from a state-regulated dispensary. But even there, oversight is uneven. “I feel safe being a cannabis consumer in Colorado, since the state tracks everything from seed to sale, but I didn’t the first few years after cannabis became legal,” when the rules were still taking shape, says Robyn Griggs Lawrence, the Boulder author of The Cannabis Kitchen Cookbook, which features recipes for cannabis edibles.
Whether the chronic pain is in your back, neck, hands, feet, or elsewhere – CBD can help! In order to understand how CBD helps provide pain relief, we turn to a series of medical studies that have been conducted over the past ten years. These studies evaluated CBD’s medical efficacy in treating those who suffer from various types of pain. We will address the results below.
Cannabis research is very much a research field. Patients need the insights that a hundred years of pharmaceutical science has done for every other plant-derived medicine that’s presently in use, by identifying each of the active ingredients, and then weighing them out milligram by milligram, so that patients know exactly what they’re taking. The Government needs to do it’s part, by moving out of the way and allowing researchers to carry out studies…at present, DEA won’t allow studies to be done and this interferes with scientific research into what’s in cannabis and why the substances in cannabis work for people. But cannabis supporters must do their part as well. Hiding from the scientific method, and hurling bizarre conspiracy theories around to impugn the motives of science researchers, is making cannabis medicine less reliable than it needs to be, for the people whose lives most depend on it. We’ve known since 1974 that something in cannabis can stop cancers from growing. Don’t we deserve to know why this works?
"Another chemical shared by both industrial hemp and marijuana is Cannabidiol (CBD).48 CBD is unique because it is not intoxicating and it also moderates the euphoric effect of THC.49 Marijuana, which has disproportionately higher levels of THC than industrial hemp, also contains lower levels of CBD.50 The higher THC and lower CBD concentration gives marijuana its psychoactive effect.51 Conversely, industrial hemp’s low THC levels and comparatively high CBD levels produce none of the intoxicating effects of marijuana.52"
Hemp is thus profitable and sustainable, two words which have eluded many U.S. farmers as of late. Hemp cultivation could provide much-needed relief as farmers struggle to find markets for millions of bushels of crops during the trade wars. Now, instead of importing an estimated $100 million of hemp products every year, that money will go to American farmers and entrepreneurs.
Personal health depends partially on the active, passive, and assisted cues people observe and adopt about their own health. These include personal actions for preventing or minimizing the effects of a disease, usually a chronic condition, through integrative care. They also include personal hygiene practices to prevent infection and illness, such as bathing and washing hands with soap; brushing and flossing teeth; storing, preparing and handling food safely; and many others. The information gleaned from personal observations of daily living – such as about sleep patterns, exercise behavior, nutritional intake and environmental features – may be used to inform personal decisions and actions (e.g., "I feel tired in the morning so I am going to try sleeping on a different pillow"), as well as clinical decisions and treatment plans (e.g., a patient who notices his or her shoes are tighter than usual may be having exacerbation of left-sided heart failure, and may require diuretic medication to reduce fluid overload).
Does anybody know about cbd vs thc for chronic exhaustion? There are times that I can barely get out of bed and can’t do work due to it, and it has gotten my mood swings to go over the roof! I don’t have much interest in doing just thc because it makes me feel more lethargic, but cbd has seem to be able to help me! I need to know if someone has used it for this problem, and is results
There has been little high-quality research into the use of cannabidiol for epilepsy, and what there is is limited to refractory epilepsy in children. While the results of using medical-grade cannabidiol in combination with conventional medication shows some promise, they did not lead to seizures being eliminated, and were associated with some minor adverse effects.
Chronic pain can be nociceptive or neuropathic. Nociceptive pain is the most common and is caused by tissue damage and inflammation. It’s characterized by throbbing, aching, and sharp pain. Neuropathic pain is caused by damage to the nervous system and can feel like stabbing, burning, or tingling pain. Studies on cannabinoids and pain demonstrate that CBD can treat both types of pain.
Ten years ago hemp cultivation was illegal in Germany, England, Canada, Australia, and other countries. Essential to overcoming governmental reluctance in each country was the presentation of an image that was business-oriented, and conservative. The merits of environmentalism have acquired some political support, but unless there is a reasonable possibility that hemp cultivation is perceived as potentially economically viable, there is limited prospect of having anti-hemp laws changed. Strong support from business and farm groups is indispensable; support from pro-marijuana interests and what are perceived of as fringe groups is generally counterproductive. It is a combination of prospective economic benefit coupled with assurance that hemp cultivation will not detrimentally affect the enforcement of marijuana legislation that has led most industrially advanced countries to reverse prohibitions against growing hemp. Should the US permit commercial hemp cultivation to resume, it will likely be for the same reasons.
You don’t always want to believe the experts, trust me on this. In fact I’ve had certain issues often on over the years were natural alternatives were the key to natural healing. In fact, when dealing with a fracture many years ago, if you recall it took about six weeks to heal. Mine healed in four or less. Now getting back to the hemp oil, It actually helps with arthritis pain in my case. I’ve also noticed if I up my magnesium levels I have lesser of a chance of having a myoclonic seizure. If you really do your homework, you’ll find out but nutritional deficiencies cause a whole host of problems if not most of them. If we weren’t meant to have the plant, it wouldn’t be here as it serves a purpose
The scientific debate regarding taxonomy has had little effect on the terminology in widespread use among cultivators and users of drug-type Cannabis. Cannabis aficionados recognize three distinct types based on such factors as morphology, native range, aroma, and subjective psychoactive characteristics. Sativa is the most widespread variety, which is usually tall, laxly branched, and found in warm lowland regions. Indica designates shorter, bushier plants adapted to cooler climates and highland environments. Ruderalis is the informal name for the short plants that grow wild in Europe and Central Asia.
In addition to safety risks, many jobs also present risks of disease, illness and other long-term health problems. Among the most common occupational diseases are various forms of pneumoconiosis, including silicosis and coal worker's pneumoconiosis (black lung disease). Asthma is another respiratory illness that many workers are vulnerable to. Workers may also be vulnerable to skin diseases, including eczema, dermatitis, urticaria, sunburn, and skin cancer. Other occupational diseases of concern include carpal tunnel syndrome and lead poisoning.
An alternative to the gateway hypothesis is the common liability to addiction (CLA) theory. It states that some individuals are, for various reasons, willing to try multiple recreational substances. The "gateway" drugs are merely those that are (usually) available at an earlier age than the harder drugs. Researchers have noted in an extensive review that it is dangerous to present the sequence of events described in gateway "theory" in causative terms as this hinders both research and intervention.
I can’t disagree more with attacking “Big Pharma” or Trump with regards to fixing this problem! Screw the political affiliations for now, let’s change the whole Schedule 1 nightmare. We’re steeped in technology and we have insanely archaic drug laws. Worse, our gov then pressures the countries we give money to (which is all of them) to follow suit by adopting our effed up way. Schedule 1 needs to be dismantled. The research can’t be done on anything listed with very few exceptions. There’s other Sched.1 drugs that need to be available for research by legitimate people, there’s lots of exciting research in psychedelics that’s stalled by archaic laws. That part might just require big pharma to help.
Despite some relatively tough talk from regulatory bodies, it can seem like they’re trying to close the barn door after the horse got out. CBD is already everywhere, and people are curious about it for reasons that seem to go far beyond trendiness, such as financial precariousness and health-care costs. “People are panicking and looking for things. They’re like, ‘What if I don’t have insurance because I get laid off? What can I replace my meds with?’” says Donahue, the Allure editor. CBD fits neatly with a growing distrust in technology and in the pharmaceutical industry, and America’s moderating view of cannabis means that many people see CBD as a safer alternative for anxiety or pain that’s worth trying.
I recently was a guest at a medical marijuana educational event that highlighted the work of researcher Michael Backes. During his presentation he made a statement about CBD that I have never heard anywhere else that CBD is “regulating” (my word) the effects of THC. I asked the Nurse Practitioner at the event, Ivy Lou Hibbitt of Certicann.com, what he meant by that and she said it was her understanding of Michael’s comment that he takes CBD to reduce the psychoactive effects of THC. Has this property of CBD, that it can lessen psychoactive effects, ever been researched elsewhere?
I always tell beginners for CBD use to use full-spectrum. The full-spectrum oils contain a lot of terpenes and other good stuff along with CBD and help much more when you suffer from anxiety attacks. CBDistillery also has a wide range of potencies to choose from. Unlike, FabCBD, which offers only limited capacities, CBDistillery’s oils go up to 5000mg per bottle and it is indeed one of the best CBD oils for pain in the market
Research suggests that CBD may exert some of its pharmacological action through its inhibition of fatty acid amide hydrolase (FAAH), which may in turn increase the levels of endocannabinoids, such as anandamide, produced by the body. It has also been speculated that some of the metabolites of CBD have pharmacological effects that contribute to the biological activity of CBD.
Thapa, D., Toguri, J. T., Szczesniak, A. M., & Kelly, A. E. M. (2017, April 1). The non-psychoactive phytocannabinoid, cannabidiol (CBD), and the synthetic derivatives, HU308 and CBD-DMH, reduces hyperalgesia and inflammation in a mouse model of corneal injury [Abstract]. FASEB Journal. https://www.fasebj.org/doi/abs/10.1096/fasebj.31.1_supplement.811.7
Cannabidiol can be taken into the body in multiple ways, including by inhalation of cannabis smoke or vapor, as an aerosol spray into the cheek, and by mouth. It may be supplied as CBD oil containing only CBD as the active ingredient (no added tetrahydrocannabinol [THC] or terpenes), a full-plant CBD-dominant hemp extract oil, capsules, dried cannabis, or as a prescription liquid solution. CBD does not have the same psychoactivity as THC, and may affect the actions of THC. Although in vitro studies indicate CBD may interact with different biological targets, including cannabinoid receptors and other neurotransmitter receptors,as of 2018 the mechanism of action for its biological effects has not been determined.